Merck & Co. Inc. buy BiotechBee
Start price
08.11.22
/
70%
€100.60
Target price
31.01.25
€150.00
Performance (%)
5.77%
End price
05.05.23
€106.40
Summary
This prediction ended on 05.05.23 with a price of €106.40. With a performance of 5.77%, the BUY prediction by BiotechBee for Merck & Co. Inc. closed with a slight gain. A total of €0.68 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Merck & Co. Inc. | 1.612% | 1.612% | 36.618% | -12.138% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % | 50,28 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % | 107,46 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % | 76,35 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % | 72,62 % |
According to BiotechBee what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Merck & Co. Inc. diskutieren
Buy mit Kursziel 150,0